Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test. Carbiotix AB (publ) was incorporated in 2014 and is based in Lund, Sweden.
Metrics to compare | CRBX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRBXPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.0x | 0.0x | −0.5x | |
PEG Ratio | −0.05 | 0.00 | 0.00 | |
Price/Book | 2.0x | 0.0x | 2.6x | |
Price / LTM Sales | 21.5x | 0.0x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.5% | |
Fair Value Upside | Unlock | 0.0% | 6.3% | Unlock |